Regeneron Pharmaceuticals
REGN
#227
Rank
โ‚ฌ77.44 B
Marketcap
704,71ย โ‚ฌ
Share price
-0.25%
Change (1 day)
-3.78%
Change (1 year)

Revenue for Regeneron Pharmaceuticals (REGN)

Revenue in 2024 (TTM): โ‚ฌ12.65 Billion

According to Regeneron Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is โ‚ฌ13.16 Billion. In 2023 the company made a revenue of โ‚ฌ11.86 Billion an increase over the revenue in the year 2022 that were of โ‚ฌ11.34 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Regeneron Pharmaceuticals from 1996 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚ฌ12.65 B6.68%
2023 โ‚ฌ11.86 B4.56%
2022 โ‚ฌ11.34 B-20.03%
2021 โ‚ฌ14.19 B105.42%
2020 โ‚ฌ6.90 B12.75%
2019 โ‚ฌ6.12 B4.45%
2018 โ‚ฌ5.86 B19.86%
2017 โ‚ฌ4.89 B5.91%
2016 โ‚ฌ4.62 B23.12%
2015 โ‚ฌ3.75 B61.89%
2014 โ‚ฌ2.31 B52.11%
2013 โ‚ฌ1.52 B46.25%
2012 โ‚ฌ1.04 B203.56%
2011 โ‚ฌ0.34 B-0.53%
2010 โ‚ฌ0.34 B30.38%
2009 โ‚ฌ0.26 B55.2%
2008 โ‚ฌ0.17 B99.2%
2007 โ‚ฌ85.62 M78.08%
2006 โ‚ฌ48.08 M-13.95%
2005 โ‚ฌ55.87 M-56.44%
2004 โ‚ฌ0.12 B179.87%
2003 โ‚ฌ45.83 M117.91%
2002 โ‚ฌ21.03 M-15.46%
2001 โ‚ฌ24.88 M-60.58%
2000 โ‚ฌ63.11 M84.1%
1999 โ‚ฌ34.28 M6.51%
1998 โ‚ฌ32.19 M15.41%
1997 โ‚ฌ27.89 M37.34%
1996 โ‚ฌ20.3 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚ฌ30.92 B 134.95%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ1.99 B-84.87%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ9.19 B-30.15%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ83.34 B 533.32%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ47.46 B 260.65%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
โ‚ฌ50.85 B 286.41%๐Ÿ‡ซ๐Ÿ‡ท France